Latest news with #KRTLHoldingGroupInc
Yahoo
4 days ago
- Business
- Yahoo
KRTL Holding Group Inc. Advances in 15c2-11 Process with Court-Approved Shareholder Verification Initiative
Lakewood, CO, June 04, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE KRTL Holding Group Inc. Advances in 15c2-11 Process with Court-Approved Shareholder Verification Initiative KRTL Holding Group Inc. (OTC: KRTL) announces a significant advancement in its journey toward full compliance with SEC Rule 15c2-11. Following a comprehensive review of legacy shareholder records predating KRTL's acquisition and restructuring, the company has successfully obtained a court order from the Third Judicial District Court, Salt Lake County, Utah. This order authorizes KRTL to initiate a structured, court-supervised verification and remediation process of legacy shareholders. Court-Approved Shareholder Verification Process Under the terms of the court order dated May 27, 2025, KRTL has commenced a rigorous program to: Send certified, court-approved notices to shareholders listed in historical records, requesting verifiable proof of ownership. Provide a 60-day window for shareholders to submit acceptable documentation, including government-issued identification and proof of stock ownership. Petition for the cancellation of shares tied to non-responsive or unverifiable shareholders through judicial declaration. Allow for discretionary reissuance in cases where late verification is provided, maintaining corporate governance standards. This proactive step is a major milestone in KRTL's efforts to cleanse its shareholder records of fictitious or unverified entries—a critical component to comply with SEC Rule 15c2-11 which governs the public quoting of OTC securities, and to facilitate Rule 144 resale eligibility, which requires a clear chain of ownership. What This Means for Our Shareholders and the Company For current and prospective shareholders, this initiative ensures a more transparent and trustworthy shareholder base. By removing legacy uncertainties, KRTL strengthens its corporate governance and enhances the integrity of its shareholder records, providing a strong foundation for future growth and regulatory standing. For KRTL, this action accelerates the company's compliance efforts with FINRA and SEC requirements, moving it significantly closer to achieving full Rule 15c2-11 compliance, a key milestone in reestablishing public market quotation and increasing shareholder value. Commitment to Transparency and Compliance 'This is a pivotal moment for KRTL Holding Group,' said Cesar Herrera, CEO of KRTL Holding Group Inc. 'We are taking decisive action to ensure the accuracy of our shareholder records and to align our operations with the highest standards of regulatory compliance. By resolving these legacy issues, we aim to restore confidence in our shareholder registry and pave the way toward improved trading access and long-term value creation.' About KRTL Holding Group Inc. KRTL Holding Group Inc. (OTC: KRTL) operates through its wholly owned subsidiaries, KRTL Biotech Inc. and KRTL International Corp. The Company leverages strategic synergies across industries to pursue investments, mergers, and partnerships that deliver shareholder value. Focused on biotech, technology, and emerging market opportunities, KRTL Holding Group is committed to growth, innovation, and operational excellence. Additional information on KRTL is available online at and and This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to differ materially from any future results, performance, or achievements expressed or implied by these forward-looking statements. Words such as "anticipates," "believes," "plans," "expects," "intends," "projects," "estimates," "future," and "opportunity" and similar expressions are used to identify these forward-looking statements. Forward-looking statements are not guarantees of future performance. These risks and uncertainties include, but are not limited to, changes in regulatory requirements, market conditions, and other factors described in the Company's filings. Additional information concerning risks and uncertainties that could materially affect KRTL's business and financial results is included in the Company's filings with the OTC Markets and, where applicable, the SEC. You should not place undue reliance on forward-looking statements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. CONTACT: info@ info@ info@ in to access your portfolio
Yahoo
24-03-2025
- Business
- Yahoo
KRTL Holding Group Announces KRTL Biotech Inc. Signs MOU with Industria Químico Farmacéutica Sigma Corp. S.R.L. to Pursue Strategic International Merger
Lakewood, CO, March 24, 2025 (GLOBE NEWSWIRE) -- KRTL Holding Group Inc. (OTC: KRTL), a diversified holding company operating through its subsidiaries KRTL Biotech, Inc. and KRTL International Corp., is pleased to announce that its wholly owned subsidiary, KRTL Biotech Inc., has signed a Memorandum of Understanding (MOU) with Industria Químico Farmacéutica Sigma Corp. S.R.L. ("Sigma") of Bolivia. This MOU establishes the framework for a strategic international merger between the two pharmaceutical entities. Under the terms of the MOU, KRTL Biotech and Sigma have agreed on key merger provisions, including a shared governance structure, consolidated financial oversight, and aligned Quality Management Systems (QMS). Sigma will maintain full operational autonomy in Bolivia, while the partnership focuses on cross-border compliance, coordinated financial operations, and integrated strategic governance. 'This MOU marks a pivotal milestone for KRTL Biotech and a transformative step in our international expansion,' stated Cesar Herrera, CEO of KRTL Holding Group Inc. 'By joining forces with Sigma, we are strengthening our global regulatory capabilities and expanding pharmaceutical production capacity across U.S. and South American markets.' As part of the agreement, Sigma will receive equity in KRTL Holding Group Inc., including one (1) Special 2021 Series A Preferred Share and representation on KRTL Holding's Board of Directors. In addition, key Sigma executives will receive individual common stock allocations to align long-term incentives. Financial integration will be managed through SIGMARTL Corp, a U.S.-based financial management entity designed to track global revenue, ensure compliance, and oversee profit-sharing mechanisms. The legal structuring and regulatory due diligence of the merger is being managed by a specialized law firm in South America, with experience in international mergers and pharmaceutical regulations. The final Business Merger Agreement, currently under development, will formalize the merger upon securing all necessary legal and financial conditions. The MOU outlines a strategic plan to consolidate Sigma's manufacturing operations and revenue streams into KRTL Biotech. This integration is intended to facilitate the import and commercialization of Sigma's pharmaceutical products in the United States under KRTL's regulatory and distribution framework. The parties believe that the merger will significantly enhance operational efficiency, enabling Sigma's production facilities—currently running at approximately 40% capacity—to scale output and achieve full utilization. Based on current figures, Sigma generates annual revenues exceeding $20 million, and the combined entity anticipates the potential to double that figure within the first two years following full integration. This initiative builds upon KRTL Biotech's ongoing strategy to establish itself as a central player in international pharmaceutical production, API oversight, and regulatory compliance. The combined operations will enhance production capacity, open new markets, and foster innovation in therapeutic development. About KRTL Holding Group Inc. KRTL Holding Group Inc. is a dynamic holding company operating through its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. These subsidiaries specialize in biopharmaceutical innovation, international trade, and compliance-driven healthcare advancements. By leveraging strategic mergers, acquisitions, and joint ventures, KRTL Holding Group continues to push the boundaries of scientific research, regulatory compliance, and global business solutions. For more information, please visit: Forward-Looking Statements This press release contains forward-looking statements under the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, anticipated business developments, regulatory advancements, and strategic growth plans. Such forward-looking statements involve known and unknown risks that may cause actual results to differ materially from those expressed or implied. KRTL Holding Group assumes no obligation to update or revise forward-looking statements, except as required by law. Any updates will be made in accordance with applicable SEC regulations and disclosure obligations. Readers are cautioned not to place undue reliance on forward-looking statements. CONTACT: info@ info@ info@ in to access your portfolio
